are highly effective at protecting people from getting sick with COVID-19, according to late-stage study results the companies announced in November. But the trials don't tell us whether the vaccines help block the virus from infecting people or stop it from jumping from person to person.
While the elderly are at the greatest risk of getting seriously ill from this virus, most of the viral spread stems from younger people, who often don't have symptoms. Asymptomatic carriers can unknowingly spread the virus to more vulnerable people, worsening the public-health crisis. Moderna and Pfizer did not respond to specific questions about this proposal. Moderna spokesperson Ray Jordan said the biotech has no data at the moment "that would be informative on asymptomatic transmission."that while he believes it's likely that his company's vaccine does prevent transmission, there's still no solid proof of that. And he cautioned that people shouldn't change their behavior after being vaccinated.
Information on how the vaccines affect the spread of the virus would help us figure out what proportion of the population needs to be vaccinated in order to halt the coronavirus' spread, said Dr. Douglas Lowy, a principal deputy director at the National Cancer Institute and a member of the ACTIV working group.A randomized trial is best way to find the transmission answer, scientists say
Hi, please check out my gig if you need any kind of graphic design
MegaWordVigil Has this generation LONGED for The Coming of The MESSIAH? 8. 이 세대는 메시아의 오심을 갈망해왔습니까?~